FindTrial
Sign In

ADH-1

DRUG2 trials

Sponsors

Adherex Technologies, Inc., University of Nebraska

Conditions

Ampulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic AdenocarcinomaNeoplasmsPancreatic AdenocarcinomaStage III Ampulla of Vater CancerStage III Intrahepatic CholangiocarcinomaStage III Pancreatic Cancer

Phase 1

A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan
CompletedNCT00421811
Adherex Technologies, Inc.Neoplasms
Start: 2007-04-30End: 2009-03-31Target: 56Updated: 2010-12-28
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
CompletedNCT01825603
University of NebraskaAmpulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma +17
Start: 2013-04-09End: 2017-06-01Updated: 2023-12-28

Related Papers

A phase I study of ADH-1 with cisplatin (Cisp) and gemcitabine (Gem) in patients (Pts) with unresectable or metastatic pancreatic and biliary tract cancers.
Journal of Clinical Oncology2017-02-012 citations